(Q51088537)

English

Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs.

scientific article published in April 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17205514

Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17205514

Marjolein van Ballegooijen

8

object named as

Marjolein van Ballegooijen

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

author name string

Aagje G Bais

1

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17205514

Folkert J van Kemenade

2

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17205514

Johannes Berkhof

3

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17205514

René H M Verheijen

4

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17205514

Peter J F Snijders

5

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17205514

Feja Voorhorst

6

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17205514

Milena Babović

7

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17205514

Theo J M Helmerhorst

9

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17205514

Chris J L M Meijer

10

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17205514

language of work or name

0 references

publication date

1 April 2007

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17205514

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17205514

120

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17205514

7

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17205514

1505-1510

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17205514

Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22484

21 January 2018

The cervical cancer epidemic that screening has prevented in the UK.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22484

21 January 2018

The Papanicolaou test for cervical cancer detection. A triumph and a tragedy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22484

21 January 2018

Human papillomavirus testing in primary cervical screening.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22484

21 January 2018

Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22484

21 January 2018

Missed opportunities for cervical cancer screening of HMO members developing invasive cervical cancer (ICC).

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22484

21 January 2018

New technologies in cervical cytology screening: a word of caution

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22484

21 January 2018

The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22484

21 January 2018

Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22484

21 January 2018

HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22484

21 January 2018

Human papillomavirus DNA testing for cervical cancer screening in low-resource settings

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22484

21 January 2018

High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22484

21 January 2018

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22484

21 January 2018

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22484

21 January 2018

Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22484

21 January 2018

GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22484

21 January 2018

The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22484

21 January 2018

Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22484

21 January 2018

Identifiers

10.1002/IJC.22484

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17205514

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17205514

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51088537&oldid=1698356553"